BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16549289)

  • 1. Evaluation of the leukocyte esterase test (LET) as pre-screening test to reduce costs for national population-based Chlamydia trachomatis screening programs.
    Morré SA; Spaargaren J; Veldhuijzen IK; Postma MJ; van Bergen JE; van Bergen JE; Broer J; Coenen AJ; Götz HM; de Groot F; Hoebe CJ; Richardus JH; van Schaik DT; Veldhuijzen IK; Verhooren M;
    J Adolesc Health; 2006 Apr; 38(4):332-3; author reply 333-4. PubMed ID: 16549289
    [No Abstract]   [Full Text] [Related]  

  • 2. Modelling the impact of opportunistic screening on the sequelae and public healthcare costs of infection with Chlamydia trachomatis in Australian women.
    Ward B; Rodger AJ; Jackson TJ
    Public Health; 2006 Jan; 120(1):42-9. PubMed ID: 16271271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine-based testing for Chlamydia trachomatis using polymerase chain reaction, leucocyte esterase and urethral and cervical smears.
    Coble BI; Nordahl-Akesson E; Vinnerberg A; Kihlström E
    Scand J Clin Lab Invest; 2006; 66(4):269-77. PubMed ID: 16777755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Swedish cost-effectiveness analysis of community-based Chlamydia trachomatis PCR testing of postal urine specimens obtained at home.
    Novak DP; Lindholm L; Jonsson M; Karlsson RB
    Scand J Public Health; 2004; 32(5):324-32. PubMed ID: 15513664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The usefulness of screening for chlamydial trachomatis infection with cervical mucus leukocyte esterase.
    el-Shourbagy M; Diab KM; Abdalla MY; el-Salam MA; Mohasb SH
    J Obstet Gynaecol Res; 1998 Feb; 24(1):21-5. PubMed ID: 9564101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for Chlamydia trachomatis infection in college women with a polymerase chain reaction assay.
    Baxter R
    Clin Infect Dis; 2000 Feb; 30(2):406-7. PubMed ID: 10671359
    [No Abstract]   [Full Text] [Related]  

  • 7. Is there a role for leucocyte esterase testing in non-invasive screening using nucleic acid amplification tests of asymptomatic men?
    Horner PJ; Taylor-Robinson D
    Int J STD AIDS; 2007 Feb; 18(2):73-4. PubMed ID: 17331273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of infections due to Chlamydia trachomatis.
    Domeika M
    Acta Obstet Gynecol Scand Suppl; 1997; 164():121-7. PubMed ID: 9225656
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chlamydia trachomatis infections--a time for action?].
    Mylonas I; Kirschner W; Weissenbacher T; Gingelmaier A; Weissenbacher ER; Friese K
    Dtsch Med Wochenschr; 2007 May; 132(21):1170-6. PubMed ID: 17506013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of costs, effectiveness, and disease control of a population-based program using home sampling for diagnosis of urogenital Chlamydia trachomatis Infections.
    Andersen B; Gundgaard J; Kretzschmar M; Olsen J; Welte R; Oster-Gaard L
    Sex Transm Dis; 2006 Jul; 33(7):407-15. PubMed ID: 16601656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women.
    Gift TL; Gaydos CA; Kent CK; Marrazzo JM; Rietmeijer CA; Schillinger JA; Dunne EF
    Sex Transm Dis; 2008 Nov; 35(11 Suppl):S66-75. PubMed ID: 18830137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chlamydia trachomatis: common misperceptions and misunderstandings.
    Stevens-Simon C; Sheeder J
    J Pediatr Adolesc Gynecol; 2005 Aug; 18(4):231-43. PubMed ID: 16171726
    [No Abstract]   [Full Text] [Related]  

  • 13. The Philadelphia High-School STD Screening Program: key insights from dynamic transmission modeling.
    Fisman DN; Spain CV; Salmon ME; Goldberg M
    Sex Transm Dis; 2008 Nov; 35(11 Suppl):S61-5. PubMed ID: 18607306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Issues in Chlamydia trachomatis testing by nucleic acid amplification test.
    Hadgu A
    J Infect Dis; 2006 May; 193(9):1335-6; author reply 1338-9. PubMed ID: 16586375
    [No Abstract]   [Full Text] [Related]  

  • 15. The silent epidemic of Chlamydia: what are we missing here?
    Sanfilippo JS
    J Pediatr Adolesc Gynecol; 2008 Oct; 21(5):231-2. PubMed ID: 18794016
    [No Abstract]   [Full Text] [Related]  

  • 16. Chlamydia trachomatis detection in cervical PreservCyt specimens from an Irish urban female population.
    Keegan H; Ryan F; Malkin A; Griffin M; Lambkin H
    Cytopathology; 2009 Apr; 20(2):111-6. PubMed ID: 18093220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High cost of Chlamydia can be cut, researcher finds.
    Silversides A
    CMAJ; 1999 Apr; 160(8):1119. PubMed ID: 10234330
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of Chlamydia trachomatis infection in infertile women at a university hospital in Jordan.
    Al-Ramahi M; Mahafzah A; Saleh S; Fram K
    East Mediterr Health J; 2008; 14(5):1148-54. PubMed ID: 19161088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What about the men?
    Dunne EF; Gift TL; Stamm WE
    Sex Transm Dis; 2008 Nov; 35(11 Suppl):S1-2. PubMed ID: 18813144
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel gel-based method for self-collection and ambient temperature postal transport of urine for PCR detection of Chlamydia trachomatis.
    Bialasiewicz S; Whiley DM; Buhrer-Skinner M; Bautista C; Barker K; Aitken S; Gordon R; Muller R; Lambert SB; Debattista J; Nissen MD; Sloots TP
    Sex Transm Infect; 2009 Apr; 85(2):102-5. PubMed ID: 19004866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.